Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2152455016 | Nicotine 4mg lozenge (product) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2160170015 | Nicotine 4mg lozenge | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763541012 | Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3763542017 | Product containing precisely nicotine (as nicotine polacrilex) 4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Is a | Nicotine lozenges | false | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has active ingredient | Nicotine | false | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has manufactured dose form | Oromucosal lozenge | true | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has manufactured dose form | Oropharyngeal dose form (dose form) | false | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Is a | Product containing only nicotine in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has presentation strength denominator unit (attribute) | Lozenge | true | Inferred relationship | Some | 1 | |
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has precise active ingredient | Nicotine polacrilex | true | Inferred relationship | Some | 1 | |
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has basis of strength substance (attribute) | Nicotine | true | Inferred relationship | Some | 1 | |
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has unit of presentation | Lozenge | true | Inferred relationship | Some | ||
| Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge | Has presentation strength numerator value | 4 | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR